These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19274934)

  • 61. [Prevention of adverse reactions to allopurinol].
    Casas E; Michán A; González Sanz A; García Puig J
    An Med Interna; 1989 Jan; 6(1):48. PubMed ID: 2491034
    [No Abstract]   [Full Text] [Related]  

  • 62. Urticaria caused by dimenhydrinate.
    Paffumi I; Saitta S; Isola S; Gangemi S
    Allergol Immunopathol (Madr); 2012; 40(4):253-4. PubMed ID: 21889831
    [No Abstract]   [Full Text] [Related]  

  • 63. DRESS syndrome associated with raltegravir.
    Zhang KS; Modi GM; Hsu S
    Dermatol Online J; 2011 Aug; 17(8):14. PubMed ID: 21906494
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Severe diphenylhydantoin hypersensitivity: analysis of 11 cases].
    Pan CH; Tsai JJ; Chee CY; Hsi MS; Luo SF
    Taiwan Yi Xue Hui Za Zhi; 1987 Jul; 86(7):750-8. PubMed ID: 3681242
    [No Abstract]   [Full Text] [Related]  

  • 65. Allopurinol: a necessary evil.
    Lim AY; Teng GG
    Singapore Med J; 2009 Sep; 50(9):925-6; author reply 927. PubMed ID: 19787189
    [No Abstract]   [Full Text] [Related]  

  • 66. Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
    Metz KA; Johnson T; Hershey GK; Lierl MB; Seidu L; Burns K; Assa'ad A
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):173-4. PubMed ID: 19230475
    [No Abstract]   [Full Text] [Related]  

  • 67. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol].
    Choi SH; Yang SH; Song YB; Kim HJ; Seo YT; Choi DS; Moon KH; Byun JH; Yu ES
    Korean J Hepatol; 2005 Mar; 11(1):80-5. PubMed ID: 15788888
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Janus faces of allopurinol-allopurinol hypersensitivity syndrome.
    Tausche AK; Aringer M; Schroeder HE; Bornstein SR; Wunderlich C; Wozel G
    Am J Med; 2008 Mar; 121(3):e3-4. PubMed ID: 18328291
    [No Abstract]   [Full Text] [Related]  

  • 69. Some cautionary notes on prescribing allopurinol.
    Page H
    JAMA; 1982 Aug; 248(5):519. PubMed ID: 7097891
    [No Abstract]   [Full Text] [Related]  

  • 70. [Drug-induced hypersensitivity syndrome: DIHS].
    Tohyama M; Hashimoto K
    Arerugi; 2007 Nov; 56(11):1346-50. PubMed ID: 18059145
    [No Abstract]   [Full Text] [Related]  

  • 71. Dimenhydrinate-induced fixed drug eruption in a patient who tolerated other antihistamines.
    Rodríguez-Jiménez B; Domínguez-Ortega J; González-García JM; Kindelan-Recarte C
    J Investig Allergol Clin Immunol; 2009; 19(4):334-5. PubMed ID: 19639740
    [No Abstract]   [Full Text] [Related]  

  • 72. Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus.
    Sommers LM; Schoene RB
    Arch Intern Med; 2002 May; 162(10):1190-2. PubMed ID: 12020192
    [No Abstract]   [Full Text] [Related]  

  • 73. An unusual case of allopurinol hypersensitivity syndrome potentiated by intravitreal bevacizumab.
    Padhy BM; Gupta YK; Shanmugam SP; Bamrolia NR
    Eur J Clin Pharmacol; 2011 May; 67(5):537-8. PubMed ID: 21069517
    [No Abstract]   [Full Text] [Related]  

  • 74. Desensitisation to allopurinol: a cautionary tale.
    Unsworth J; Blake DR; d'Assis Fonseca AE; Beswick DT
    Ann Rheum Dis; 1987 Aug; 46(8):646. PubMed ID: 3662656
    [No Abstract]   [Full Text] [Related]  

  • 75. Desensitisation to allopurinol.
    Ridley MG; Mathews JA
    Ann Rheum Dis; 1987 Nov; 46(11):875. PubMed ID: 3426293
    [No Abstract]   [Full Text] [Related]  

  • 76. Cell-mediated immunity in allopurinol-induced hypersensitivity.
    Braden GL; Warzynski MJ; Golightly M; Ballow M
    Clin Immunol Immunopathol; 1994 Feb; 70(2):145-51. PubMed ID: 8299230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allopurinol induced DRESS syndrome without eosinophilia and pronounced mucosal involvement.
    Rakusa J; Lautenschlager S; Chmiel C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):865-7. PubMed ID: 25690468
    [No Abstract]   [Full Text] [Related]  

  • 78. Long-lasting dermatological lesions after tiludronate therapy.
    Roux C; Listrat V; Villette B; Lessana-Leibowitch M; Ethgen D; Pelissier C; Dougados M; Amor B
    Calcif Tissue Int; 1992 Apr; 50(4):378-80. PubMed ID: 1571850
    [No Abstract]   [Full Text] [Related]  

  • 79. Up to 70% of HIV-positive individuals report experiencing symptoms related to atopy.
    Brennan C
    HIV Clin; 2015; 27(1):1-10. PubMed ID: 26159003
    [No Abstract]   [Full Text] [Related]  

  • 80. Mastocytosis.
    Golkar L; Bernhard JD
    Lancet; 1997 May; 349(9062):1379-85. PubMed ID: 9149712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.